Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Breast and cervical cancer rates influenced by HRT, not contraceptive pill
Prof Valerie Beral - University of Oxford, Oxford, UK
Breast and cervical cancer rates influenced by HRT, not contraceptive pill ( Prof Valerie Beral - University of Oxford, Oxford, UK )
30 Jun 2016
Editor's Choice for March 2016
Prof Gordon McVie - ecancer Editor
Editor's Choice for March 2016 ( Prof Gordon McVie - ecancer Editor )
31 Mar 2016
Advanced prostate cancer overview: Expert discussion
Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders
Advanced prostate cancer overview: Expert discussion ( Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders )
27 Jan 2016
Best of ASCO GU 2016 prostate cancer data
Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson
Best of ASCO GU 2016 prostate cancer data ( Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson )
8 Jan 2016
ASCO GU 2016: Highlights
Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
ASCO GU 2016: Highlights ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
8 Jan 2016
Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets
Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA
Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
From genotype to molecular phenotype by proteomics
Dr Janne Lehtiö - Karolinska Institutet, Stockholm, Sweden
From genotype to molecular phenotype by proteomics ( Dr Janne Lehtiö - Karolinska Institutet, Stockholm, Sweden )
22 Dec 2015
ER and FGFR1 interaction critical in endocrine resistant breast cancer
Dr Luigi Formisano - Vanderbilt University Nashville, USA
ER and FGFR1 interaction critical in endocrine resistant breast cancer ( Dr Luigi Formisano - Vanderbilt University Nashville, USA )
16 Dec 2015
Interrupting breast cancer treatment for young women who desire pregnancy
Dr Olivia Pagani and Dr Ann Partridge
Interrupting breast cancer treatment for young women who desire pregnancy ( Dr Olivia Pagani and Dr Ann Partridge )
16 Dec 2015
No significant difference in recurrence rates among women with DCIS taking...
Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United...
No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )
11 Dec 2015
Treating women with endocrine-resistant HR /HER2 advanced breast cancer
Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie...
Treating women with endocrine-resistant HR /HER2 advanced breast cancer ( Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. )
11 Dec 2015
No significant difference in recurrence rates among women with DCIS taking...
Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United...
No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )
11 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation